1. Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence 
Christian Toso, Gilles Mentha, Pietro Majno 
Journal of Hepatology 
Volume 59, Issue 1, Pages 3-5 (July 2013)
DOI: /j.jhep
Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Proposed management of patients with post-transplant HCC recurrence. mTOR, mammalian target-of-rapamycin; RFA, radiofrequency ablation; TACE, transarterial chemo-embolization; TARE, transarterial radio-embolization. ∗Treatment invasiveness should be modulated according to the expected outcome: late recurrences have better potential outcomes and may warrant more aggressive approaches. ∗∗Alone or combined to hepatic HCC recurrence.
Journal of Hepatology  , 3-5DOI: ( /j.jhep )
Copyright © 2013 European Association for the Study of the Liver Terms and Conditions